Correlation Between SCANDMEDICAL SOLDK-040 and Swiss Life

Can any of the company-specific risk be diversified away by investing in both SCANDMEDICAL SOLDK-040 and Swiss Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SCANDMEDICAL SOLDK-040 and Swiss Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SCANDMEDICAL SOLDK 040 and Swiss Life Holding, you can compare the effects of market volatilities on SCANDMEDICAL SOLDK-040 and Swiss Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SCANDMEDICAL SOLDK-040 with a short position of Swiss Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of SCANDMEDICAL SOLDK-040 and Swiss Life.

Diversification Opportunities for SCANDMEDICAL SOLDK-040 and Swiss Life

0.26

Correlation Coefficient

SCANDMEDICAL SOLDK-040  Swiss Life

Modest diversification

The 3 months correlation between SCANDMEDICAL and Swiss is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding SCANDMEDICAL SOLDK 040 and Swiss Life Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Swiss Life Holding and SCANDMEDICAL SOLDK-040 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SCANDMEDICAL SOLDK 040 are associated (or correlated) with Swiss Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Swiss Life Holding has no effect on the direction of SCANDMEDICAL SOLDK-040 i.e., SCANDMEDICAL SOLDK-040 and Swiss Life go up and down completely randomly.

Pair Corralation between SCANDMEDICAL SOLDK-040 and Swiss Life

Assuming the 90 days horizon SCANDMEDICAL SOLDK 040 is expected to generate 3.37 times more return on investment than Swiss Life. However, SCANDMEDICAL SOLDK-040 is 3.37 times more volatile than Swiss Life Holding. It trades about 0.02 of its potential returns per unit of risk. Swiss Life Holding is currently generating about 0.05 per unit of risk. If you would invest  100.00  in SCANDMEDICAL SOLDK 040 on October 11, 2024 and sell it today you would lose (27.00) from holding SCANDMEDICAL SOLDK 040 or give up 27.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

SCANDMEDICAL SOLDK 040  vs.  Swiss Life Holding

SCANDMEDICAL SOLDK 040

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, SCANDMEDICAL SOLDK-040 is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Swiss Life Holding

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Swiss Life Holding are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Swiss Life is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with SCANDMEDICAL SOLDK-040 and Swiss Life

The main advantage of trading using opposite SCANDMEDICAL SOLDK-040 and Swiss Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SCANDMEDICAL SOLDK-040 position performs unexpectedly, Swiss Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Swiss Life will offset losses from the drop in Swiss Life's long position.

The idea behind SCANDMEDICAL SOLDK 040 and Swiss Life Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.